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The pivotal role of nucleotides in cell function and metabolism
has been acknowledged for more than three decades since the
milestone work of Sutherland [1]. Intracellular nucleotides are
involved in each and every event of cell life including synthesis of
nuclear material, phosphorylation processes, or transduction of
extracellular signals. As regards to this last point, a huge number
of studies has been devoted to identifying the key role of
GTP-binding proteins or G proteins, on the one hand, and of
cyclic nucleotides cAMP and cGMP, on the other hand, in the
early steps of cell signaling. In epithelial cells such as renal tubular
cells, generation of these mediators as a hallmark of cell-hormone
interaction has been investigated in detail [reviewed in 2].
More recently, experimental evidence was provided showing
that extracellular nucleotides are able to affect virtually every
organ and/or tissue system. These aspects have been extensively
reviewed [3—7] and will not be discussed here. Instead, attention
will be focused on the effect of extracellular nucleotides, primarily
cAMP, on renal tubular transport of inorganic phosphate (Pi).
The initial observations that systemic infusion of cAMP to
parathyroidectomized rats induced phosphaturia, thus mimicking
the proximal effect of parathyroid hormone (PTH), drew atten-
tion on the effects of extracellular cAMP on renal function [8, 9].
A striking feature was that other renal effects of PTH (modulation
of calcium or magnesium excretion), which take place beyond the
proximal tubule, or renal effects of other peptidic hormones that
act through the cAMP-protein kinase A pathway in distal parts of
the nephron, such as antidiuteric hormone, were not reproduced
by cAMP infusion [9]. Along the same line, glucagon, infused or
injected at large pharmacological doses that induced a rise of
plasma cAMP concentration from hepatic origin and urine excre-
tion of the nucleotide [8, 10], was shown to increase phosphate
excretion [8]. These data raised the possibility that handling
(metabolism and/or transport) of extracellular cAMP by proximal
cells was involved in the effect of the cyclic nucleotide on Pi
transport.
In contrast with the extreme experimental conditions described
above, physiological situations are characterized by a fairly con-
stant systemic cAMP concentration, while luminal cAMP concen-
tration varies with the parathyroid status [10—12]. These observa-
tions suggest that luminal cAMP may act as local paracrine
modulator of Pi transport and raise three questions: (a) How does
cAMP reach the extracellular space under normal situations; (b)
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How is cAMP "sensored" by neighbor cells; and (c) Is Pi transport
affected by physiological or pathological modulation of cAMP
handling.
How does cAMP reach the tubular fluid?
Because cyclic and non-cyclic nucleotides are all generated
within the cell, a possible effect of these compounds from the
extracellular side, more specifically from the apical, luminal side
of tubular cells, raises the question of how they exit from the cells.
Other questions include, which transport systems are involved, are
these systems regulated, and are they inserted in a polarized
fashion in the plasma membrane of epithelial cells.
Extrusion of cAMP from renal tubular cells into the tubular
lumen was suggested by the observation that urinary cAMP
excretion exceeds the filtered load except in the absence of PTH
[8, 10, 11, 13]. The difference between excreted and filtered cAMP
is commonly known as nephrogenous cAMP and is a sensitive and
accurate marker of parathyroid function [12, 13]. Micropuncture
data demonstrated that the bulk of cAMP added to the urine is
transferred in the proximal convoluted tubule [13]. It is very likely,
therefore, that apical transport of cAMP occurs in this nephron
segment.
The mechanism of cAMP extrusion was examined in cultured
LLC-PK1 cells, a renal epithelial cell line which possesses a mixed
proximal/distal phenotype (Na-glucose cotransport, vasopressin-
stimulated adenylate cyclase and phospholipase C, PTH-insensi-
tive Na-dependent Pi uptake), grown on permeant supports [12].
Upon stimulation of adenylate cyclase, cAMP mainly accumu-
lated in the apical bath and, to a much lesser extent, in the
basolateral compartment [14]. Apical cAMP efflux was tempera-
ture-dependent and was inhibited by prohenecid, an organic anion
transport inhibitor, by metabolic and phosphodiesterase inhibi-
tors, but not by prostaglandins or cAMP analogs, suggesting that
protein kinase A was not involved in activation of cAMP efflux. In
contrast, the small basal cAMP efflux was insensitive to probene-
cid.
The identification of the mechanisms and modulation of cAMP
efflux from mammalian cells is not a topic that is restricted to
renal tubular cells, and was also examined in nonpolarized cells
such as erythrocytes or smooth muscle cells [15, 16]. In the
latter, sensitivity of cAMP efflux to probenecid and lack of
modulation by protein kinase A was evidenced. In smooth
muscle cells in which cAMP generation was stimulated by
adenosine, adenosine receptor occupancy was mandatory for
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the maintainance of cAMP efflux, suggesting that an intracel-
lular signaling system, distinct from the cAMP-protein kinase
A pathway, may be involved in modulation of the activity of the
cAMP transport system(s),
The question of whether urinary cAMP might originate in part
from plasmatic cAMP after tubular secretion from the peritubular
space to the lumen has been addressed in several studies with
conflicting results [17, 18]. It is very likely that, if any, the amount
of cAMP reaching the tubular lumen through this pathway is
modest for at least two reasons: (i) the affinity of a basolateral
transport system of organic anions for cAMP is very low, in the
millimolar range [191, as compared to plasma concentration of the
cyclic nucleotide, which is around 10 nM [9, 10]; and (ii) renal
clearance of systemically infused tritiated cAMP equals the gb-
merular filtration rate, suggesting that plasmatic cAMP is purely
filtered [17].
If one assumes that cyclic nucleotides cAMP and cGMP share
common or similar extrusion pathways, additional information
regarding the mechanism of cAMP effiux can be obtained from
studies performed with cGMP. Indeed, in vivo experiments dem-
onstrated the existence of nephrogenous cGMP excretion in rats
infused with atrial natriuretic peptide (ANP) [20]. That luminal
cGMP in excess to the filtered load was originating from the
Bowman space was established by micropunctures [20]. The
pattern of cGMP effiux was examined in vitro in cultured SV40-
transformed human glomerular visceral epithelial cells grown on
filters [21, 22]. cGMP, generated under the influence of ANP, was
exported almost entirely to the apical bath. Efflux was inhibited by
probenecid and nocodazole, a microtubule disrupter, but not by
cytochalasin, an actin filament disrupter [22]. This suggests that
apical delivery of the transport system responsible for cGMP
extrusion was dependent on the integrity of the microtubule
network [23].
The nature of the transport system(s) responsible for effiux of
cyclic nucleotides has not been established. As discussed above,
this transporter shares some properties with an organic acid
transporter inasmuch as both are sensitive to probenecid. In the
rat proximal tubule, the affinity of such a transporter for various
nucleotides has been examined [19] and was found to be much
greater for cGMP or for cAMP analogs than for cAMP. This
feature would account for an effiux of both cAMP and cGMP
despite the fact that intracellular concentration of cGMP is
usually much lower than that of cAMP [24]. Other candidates for
cyclic nucleotide transport through plasma membranes, among
which is the cyclase itself, have been suggested on the basis of
topological similarities between this enzyme and channels or
transporters [25].
Many questions remain presently unanswered regarding the
routes of membrane riucleotide transport, their regulation by
hormones and mediators, the involvement of intracellular signal-
ing pathways and possible genetic or acquired abnormalities of
these steps. The low amount of data in this field contrasts with
numerous studies concerning both adenosine transport by renal
tubular plasma membranes [26—29] and degradation of extracel-
lular nucleotides in the tubular lumen by brush-border membrane
enzymes [30]. It is likely that acknowlegment of extracellular
nucleotides as potent and ubiquitous modulators of cell function
will bring more attention on the transport systems involved in the
exit of these compounds from mammalian cells.
Modulation of renal phosphate transport by luminal cAMP
As discussed above, luminal concentrations of cAMP may
increase upon stimulation of generating systems, that is, PTH-
sensitive adenylate cyclase. In contrast, plasmatic (basolateral)
concentrations of cAMP were shown to be fairly constant under
physiological circumstances [10, 11, 13]. This raises the possibility
that luminal cAMP influences the activity of transport systems in
renal tubular cells.
To elucidate the mechanism underlying extracellular cAMP-
induced inhibition of proximal phosphate transport, in vitro
studies were performed in opossum kidney (OK) cells, a renal
epithelial cell line with proximal phenotype in which the activity of
Na-phosphate cotransport system is inhibited by PTH [31, 32]. In
these cells, addition of cAMP to the extracellular medium induced
an inhibition of sodium-phosphate cotransport activity [33]. The
effect of cAMP was blunted by agents that prevented extracellular
degradation of the nucleotide into adenosine: inhibitors of phos-
phodiesterases, which convert cAMP to 5'-AMP, and inhibitors of
ecto-5'-nucleotidase, which transform 5'-AMP into adenosine. In
contrast, adenosine, AMP, ADP and ATP to a certain extent
reproduced the effect of cAMP. Moreover, adenosine uptake was
a mandatory step in the action of cAMP, since dipyridamole,
which is a well-known inhibitor of adenosine uptake in many cell
types including renal tubular cells [26—28], abolished the effect of
cAMP. Incubation of cells with labeled cAMP confirmed that
accumulated intracellular radioactive material was found first in
adenosine, followed by AMP, ATP, and ultimately cAMP,
Intracellular steps following adenosine entry are not yet com-
pletely understood. It has been established that adenosine is
phosphorylated into ATP. This is the basis of the protective effect
of extracellular nucleotides against ATP depletion during isch-
emia [34, 35]. However, that conversion of intracellular adenosine
into ATP is instrumental in inhibition of phosphate uptake
remains to be demonstrated. Alternatively, adenosine may affect
phosphodiesterase activity and thereby inhibit phosphate trans-
port [36, 37]. These results, obtained in OK cells, are in line with
the previous observation that rabbit proximal tubules in suspen-
sion catabolized extracellular cAMP [38].
In vivo, the physiological relevance of this pathway was assessed
by the fact that dipyridamole infusion reduced by approximately
one third phosphate excretion in PTH-infused parathyroidecto-
mized rats or in intact rats [33]. We have recently proven that this
pathway was instrumental in humans and that dipyridamole
infusion decreased phosphate excretion in normal subjects, in
patients with primary hyperparathyroidism, and in hypophos-
phatemic patients with renal phosphate leak unrelated to PTH
hypersecretion [39]. This indicates that luminal cAMP partici-
pates to the overall phosphaturic effect of PTH and that nephro-
genous cAMP, extruded into the tubular lumen in the proximal
convoluted tubule under the influence of PTH, acts downstream,
most likely in the proximal straight tubule, to modulate sodium-
phosphate cotransport activity in this segment. Furthermore, data
in humans suggest that pharmacological inhibition of adenosine
uptake may be useful to reduce renal phosphate leak. We have
recently obtained evidence that chronic administration of dipyri-
damole corrected hypophosphatemia in patients with hyperphos-
phaturia and that this treatment increased the renal Pi threshold.
It is noteworthy that a somewhat similar metabolic cascade has
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Fig. 1. Mode of action of luminal CAMP on Pi
transport. cAMP, either filtered by the glomeruli
or extruded from tubular cells to the lumen, is
catabolized into adenosine which is uptaken by
the cells and metabolized, cAMP produced
from adenosine inhibits Na-Pi cotransport
activity. PTH stimulates membrane-bound 5'-
nucleotidase activity via PKC activation.
Abbreviations are: AC, adenylate cyclase;
ADO, adenosine; DAG, diacylglycerol; PKA,
protein kinase A; PKC, protein kinasc C; PLC,
phospholipase C; PDE, phosphodiesterase; NO,
nitric oxidc; 5'-NU, 5'-nucleotidase; PTH,
parathyroid hormone. Thick unbroken arrows
denote stimulatory effect, thick dotted arrows
denote itihibitory effect.
been found in the intestinal epithelium during intestinal inflam-
matory diseases [40]; activated neutrophils located in the lumen
release 5'-AMP, which is converted to adenosine by ecto-5'-
nucleotidase of the apical membrane of intestinal epithelial cells.
Subsequent binding of adenosine to apical membrane receptors
promotes chloride secretion, which in turn drives isotonic fluid
secretion [401. A striking difference between the intestinal model
and the proximal tubule is that adcnosine must enter tubular cells
to promote phosphaturia.
It should be mentioned that Coulson et al reported that
adenosine A1 receptor agonists stimulated phosphate and glucose
uptake in OK cells through a protein kinase C-sensitive pathway
[41]. These data are consistent with the observation made by
Balakrishnan, Coles and Williams that FK-453, a selective aden-
osine A1-receptor antagonist, promotes phosphaturia in healthy
human subjects [42]. The results of these different studies are not
conflicting; preventing adenosine entry into tubular cells may
increase available adenosine for binding to A1 receptors, which in
turn mediate adenosine-induced phosphate reabsorption.
Modulation of proximal cAMP degradation affects Pi transport
Hydrolysis of AMP into adenosine by ecto-5'-nucleotidase is
the limiting step of the metabolic cascade leading to inhibition of
Pi transport by extracellular cAMP. One could therefore hypoth-
esize that the activity of 5'-nucleotidase is modulated by endo-
crine or autocrine/paracrinc agents. We have demonstrated, in
OK cells, that PTH stimulates ecto-5'-nucleotidasc activity [43];
PTH increased 5'-AMP degradation into adenosine in a time-,
concentration-, and protein synthesis-dependent manner. Protein
kinase C, but not protein kinase A, was instrumental in this effect
as evidenced by stimulation of similar magnitude induced by
[1—34] and [3—34] fragments of PTH and by phorhol-myristate
acetate, but not by forskolin or dihutyryl cAMP [44]. Stimulation
of 5'-nucleotidase activity resulted in reinforcement of cAMP-
induced inhibition of phosphate transport. It appears, therefore,
that the phosphaturic effect of PTH results from a triple action on
proximal cells: direct inhibitory effect on phosphate transport,
generation of cAMP which is mostly extruded in the luminal fluid,
and, finally, stimulation of luminal cAMP degradation through
stimulation of ecto-5'-nucleotidasc (Fig. 1).
Paracrine modulation of 5'-nucleotidase is illustrated by the
effect of nitric oxide (NO) on the enzyme. NO donors, such as
sodium nitroprusside, or NO itself inhibited 5'-nucleotidase
through a direct interaction with the enzyme that was indepen-
dent from cyclic GMP generation. Biochemical evidence of
S-nitrosylation of 5'-nucleotidase has been obtained. As expected,
inactivation of 5'-nucleotidase by NO blunted the inhibitory effect
of extracellular cAMP on Na-Pi cotransport. Modulation of
5'-nucleotidase by NO is instrumental in vivo inasmuch as inhibi-
tion of ccto-5'-nucleotidase induced by renal ischemia/reperfu-
sion in the rat was prevented by infusion of NO-synthase inhibi-
tors such as L-NAME.
Conclusion
In this brief review, the modulatory effect of extracellular
cAMP on renal phosphate transport has been discussed. Identi-
fication of genetic or acquired abnormalities of these local loops,
pharmacological modulation of generation and/or metabolism or
binding of extracellular nucleotides are among the future goals in
this new and fascinating field of investigation in renal physiology
and pathophysiology.
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